HIV/TB dual infection cause for concern.
Servilio
J
J
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000401:mortality* / Q000635:transmission; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D009518:New York / Q000453:epidemiology; D011718:Pyrazinamide / Q000627:therapeutic use; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use; D015996:Survival Rate; D013792:Thalidomide / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000401:mortality* / Q000635:transmission; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects
D014409:Tumor Necrosis Factor-alpha; D011718:Pyrazinamide; D013792:Thalidomide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin